5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 1, Pages 21
Publisher
MDPI AG
Online
2018-12-21
DOI
10.3390/ijms20010021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses
- (2018) Daniela Matei et al. CLINICAL CANCER RESEARCH
- Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells
- (2018) Luc Gailhouste et al. MOLECULAR THERAPY
- Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
- (2018) Luc Gailhouste et al. Cell Death & Disease
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- Platinum-refractory germ cell tumors: an update on current treatment options and developments
- (2016) Christoph Oing et al. WORLD JOURNAL OF UROLOGY
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Digging deep into “dirty” drugs – modulation of the methylation machinery
- (2015) Lisa Pleyer et al. DRUG METABOLISM REVIEWS
- The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer
- (2014) F. Fang et al. CLINICAL CANCER RESEARCH
- Quinone–carbohydrate nonglucoside conjugates as a new type of cytotoxic agents: Synthesis and determination of in vitro activity
- (2014) Dmitry N. Pelageev et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Seminoma and Embryonal Carcinoma Footprints Identified by Analysis of Integrated Genome-Wide Epigenetic and Expression Profiles of Germ Cell Cancer Cell Lines
- (2014) Yvonne G. van der Zwan et al. PLoS One
- Cisplatin resistance in germ cell tumours: models and mechanisms
- (2014) C. Jacobsen et al. Andrology
- Chromatin-modifying agents in anti-cancer therapy
- (2012) Carole Seidel et al. BIOCHIMIE
- Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair
- (2012) Annabelle E. Fenske et al. CANCER LETTERS
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- Proteomic Profiling of Germ Cell Cancer Cells Treated with Aaptamine, a Marine Alkaloid with Antiproliferative Activity
- (2012) Sergey A. Dyshlovoy et al. JOURNAL OF PROTEOME RESEARCH
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma
- (2011) M Brait et al. BRITISH JOURNAL OF CANCER
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance
- (2010) Hendrik Wermann et al. JOURNAL OF PATHOLOGY
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- Targeting DNA methylation for epigenetic therapy
- (2010) Xiaojing Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes
- (2009) Shinsuke Furukawa et al. CANCER SCIENCE
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Rethinking how DNA methylation patterns are maintained
- (2009) Peter A. Jones et al. NATURE REVIEWS GENETICS
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started